On the recordAugust 3, 2017
I want to say I am really pleased we are moving forward on the FDA Reauthorization Act today. This is really a great example about how Congress can actually work together on health issues and compromise and solve challenges by putting patients and families first. As my colleagues well know, these so-called user fee agreements are essential to supporting FDA's operation and mission. They allow FDA to meet the complex challenges of the 21st century technology and the movement toward precision medicine, and they help ensure that FDA upholds the gold standard of approval while evaluating new drugs and devices efficiently. Put simply, passing the FDA Reauthorization Act is absolutely necessary if Congress wants to advance safe, effective and innovative medical products for patients and families across the country. I would add, when we pass this reauthorization today, more than 5,000 employees at FDA will be able to continue their critical work without worry of interruption, employees that worked every day to protect the health and families and advance medical innovations to patients. So I am really pleased to have worked alongside the chairman of our HELP Committee, the Senior Senator from Tennessee, and all of our colleagues on and off the committee to bring to the floor these finalized agreements.…





